Phase I Safety and Preliminary Efficacy of Acalabrutinib, Venetoclax, and Obinutuzumab (AVO) in Patients with Relapsed/Refractory Mantle Cell Lymphoma
Austin I. Kim,Philippe Armand,Robert A. Redd, Megan Forsyth, Paul Branch,Samantha Pazienza,Lisa Brennan,Victoria Patterson, Susan M. Waisgerber,Reid W. Merryman,David C. Fisher,Christine E. Ryan,Inhye E. Ahn,Jennifer L. Crombie,Oreofe O. Odejide,Ann LaCasce,Caron A. Jacobson,Eric Jacobsen,Erin M. Parry,Matthew S. Davids,Jennifer R. Brown,Arnold S. Freedman,Peter A. Riedell,Mark Alan Murakami BLOOD(2023)
AI 理解论文
溯源树
样例